VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Pathogen Page
West Nile virus

Table of Contents

  1. General Information
    1. NCBI Taxonomy ID
    2. Disease
    3. Introduction
    4. Microbial Pathogenesis
    5. Host Ranges and Animal Models
    6. Host Protective Immunity
  2. Vaccine Related Pathogen Genes
    1. C protein
    2. E protein
    3. PrM
  3. Vaccine Related Host Genes
    1. IgG
  4. Vaccine Information
    1. ALVAC-WNV-prM/E
    2. ALVAC-WNV-PrM/E (dogs and cats)
    3. Encephalomyelitis-Influenza-West Nile Virus Eastern & Western, Killed Virus Vaccine (USDA: 13W5.20)
    4. Encephalomyelitis-Rhinopneumonitis-Influenza-West Nile Virus Eastern & Western, Killed Virus, Killed Flavivirus Chimera Vaccine-Tetanus Toxoid (USDA: 4855.R2)
    5. Encephalomyelitis-West Nile Virus Eastern & Western & Venezuelan, Killed Virus Vaccine (USDA: 14W5.23)
    6. Encephalomyelitis-West Nile Virus Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 48W5.20)
    7. Encephalomyelitis-West Nile Virus Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 48W5.23)
    8. Encephalomyelitis-West Nile Virus Eastern & Western, Killed Virus Vaccine (USDA: 14W5.22)
    9. Encephalomyelitis-West Nile Virus Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 48W5.21)
    10. Encephalomyelitis-West Nile Virus Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 48W5.22)
    11. Encephalomyelitis-West Nile Virus Eastern & Western, Killed Virus, Live Canarypox Vector Vaccine (USDA: 14W7.R0)
    12. Encephalomyelitis-West Nile Virus Eastern & Western, Killed Virus, Live Canarypox Vector Vaccine-Tetanus Toxoid (USDA: 48W9.R0)
    13. PreveNile
    14. RECOMBITEKEquine WNV
    15. rMV- WNV
    16. rWN/DEN4Δ30
    17. West Nile virus C protein mutant vaccine
    18. West Nile Virus DNA Vaccine (USDA: 1995.D0)
    19. West Nile virus DNA vaccine pCBWN encoding prM and E
    20. West Nile Virus Killed Virus Vaccine (USDA: 1995.20)
    21. West Nile Virus Killed Virus Vaccine (USDA: 1995.22)
    22. West Nile Virus Live Canarypox Vector Vaccine (USDA: 1991.R0)
    23. West Nile Virus Live Flavivirus Chimera Vaccine (USDA: 1991.R1)
    24. West Nile-Innovator DNA
    25. WNV recombinant E protein vaccine (WN-80E)
  5. References
I. General Information
1. NCBI Taxonomy ID:
11082
2. Disease:
West Nile fever
3. Introduction
West Nile virus (WNV) is a virus of the family Flaviviridae. Part of the Japanese encephalitis (JE) antigenic complex of viruses, it is found in both tropical and temperate regions. It mainly infects birds, but is known to infect humans, horses, dogs, cats, bats, chipmunks, skunks, squirrels, and domestic rabbits. The main route of human infection is through the bite of an infected mosquito (Wiki: West Nile). WNV was first detected in North America in 1999 and spread rapidly across the USA and into Canada, Mexico, and Central and South America. The virus is transmitted via mosquitoes, primarily through the bite of Culex species but also by many other genera of mosquitoes. Birds are the natural hosts and serve as the zoonotic reservoir. Mammals and reptiles are considered to be incidental hosts from which further transmission generally does not occur (Lieberman et al., 2009).
4. Microbial Pathogenesis
The mechanisms by which WNV and other neurotropic flaviviruses cross the blood-brain barrier (BBB) remain largely unknown, although tumor necrosis factor alpha (TNF-α)-mediated changes in endothelial cell permeability may facilitate CNS entry. It is likely that WNV infects the CNS at least in part via hematogenous spread, as an increased viral burden in serum correlates with earlier viral entry into the brain. Additional mechanisms may contribute to WNV CNS infection, including (i) infection or passive transport through the endothelium or choroid plexus epithelial cells, (ii) infection of olfactory neurons and spread to the olfactory bulb, (iii) a “Trojan horse” mechanism in which the virus is transported by infected immune cells that traffic to the CNS, and (iv) direct axonal retrograde transport from infected peripheral neurons (Samuel and Diamond, 2006).
5. Host Ranges and Animal Models
West Nile virus mainly infects birds, but is known to infect humans, horses, dogs, cats, bats, chipmunks, skunks, squirrels, and domestic rabbits. The main route of human infection is through the bite of an infected mosquito (Wiki: West Nile).
6. Host Protective Immunity
T-cell-mediated immunity is essential for controlling WNV infection in the CNS. Both humoral and cellular immune responses are likely essential in protection from WNV infection (Samuel and Diamond, 2006).
Loading...
Loading Pathogen Genes...
Loading...
Loading Host Genes...
Loading...
Loading Vaccines...
Loading References...